Comparative study of recent wide-pore materials of different stationary phase morphology, applied for the reversed-phase analysis of recombinant monoclonal antibodies by Fekete, Szabolcs et al.
ORIGINAL PAPER
Comparative study of recent wide-pore materials of different
stationary phase morphology, applied for the reversed-phase
analysis of recombinant monoclonal antibodies
Szabolcs Fekete & Jean-Luc Veuthey & Sebastiaan Eeltink &
Davy Guillarme
Received: 3 October 2012 /Revised: 11 January 2013 /Accepted: 16 January 2013 /Published online: 29 January 2013
# Springer-Verlag Berlin Heidelberg 2013
Abstract Various recent wide-pore reversed-phase station-
ary phases were studied for the analysis of intact monoclo-
nal antibodies (mAbs) of 150 kDa and their fragments
possessing sizes between 25 and 50 kDa. Different types
of column technology were evaluated, namely, a prototype
silica-based inorganic monolith containing mesopores of
∼250 Å and macropores of ∼1.1 μm, a column packed with
3.6 μm wide-pore core-shell particles possessing a wide
pore size distribution with an average around 200 Å and a
column packed with fully porous 1.7 μm particles having
pore size of ∼300 Å. The performance of these wide-pore
materials was compared with that of a poly(styrene–divinyl
benzene) organic monolithic column, with a macropore size
of approximately 1 μm but without mesopores (stagnant
pores). A systematic investigation was carried out using
model IgG1 and IgG2 mAbs, namely rituximab, panitumu-
mab, and bevacizumab. Firstly, the recoveries of intact and
reduced mAbs were compared on the two monolithic
phases, and it appeared that adsorption was less pronounced
on the organic monolith, probably due to the difference in
chemistry (C18 versus phenyl) and the absence of meso-
pores (stagnant zones). Secondly, the kinetic performance
was investigated in gradient elution mode for all columns.
For this purpose, peak capacities per meter as well as peak
capacities per time unit and per pressure unit (PPT) were
calculated at various flow rates, to compare performance of
columns with different dimensions. In terms of peak capac-
ity per meter, the core-shell 3.6 μm and fully porous 1.7 μm
columns outperformed the two monolithic phases, at a tem-
perature of 60 °C. However, when considering the PPT
values, the core-shell 3.6 μm column remained the best
phase while the prototype silica-based monoliths became
very interesting, mostly due to a very high permeability
compared with the organic monolith. Therefore, these
core-shell and silica-based monolith provided the fastest
achievable separation. Finally, at the maximal working tem-
perature of each column, the core-shell 3.6 μm column was
far better than the other one, because it is the only one stable
up to 90 °C. Lastly, the loading capacity was also measured
on these four different phases. It appeared that the organic
monolith was the less interesting and rapidly overloaded,
due to the absence of mesopores. On the other hand, the
loading capacity of prototype silica-based monolith was
indeed reasonable.
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Introduction
In reversed-phase liquid chromatography (RPLC), there
have been a significant number of innovations in terms of
instrumentations and column technology during the last
decade. The goal of these new technologies was to perform
either faster analysis or to attain higher resolution. These
advances have mainly been driven by the constant increase
in the number of analyses or in sample complexity. These
innovative strategies were generally developed for small
molecules, but nowadays, RPLC also becomes a relevant
strategy for the analysis of large biomolecules, such as
therapeutic peptides, proteins, or monoclonal antibodies.
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Indeed, size exclusion chromatography and ion exchange
chromatography are considered as reference techniques for
analyzing such biomolecules but suffer from low kinetic
performance and difficult coupling with mass spectrometry.
Since high-molecular-weight proteins have large hydrody-
namic radii, wide-pore RPLC stationary phases are manda-
tory for the analysis of mAbs and their fragments. There are
now several novel RPLC stationary phases, commercially
available with wide pores (200–300 Å at least).
Monolithic stationary phases are promising materials to
improve chromatographic performance [1, 2]. They have orig-
inally been developed byHjerten [3], Svec and Frechet [4], and
Tanaka and Nakanishi [5] during the 1990s. Various types of
inorganic (e.g., silica, zirconia, carbon, titania) or organic (e.g.,
polymethacrylate, polyacrylamide, poly(styrene–divinylben-
zene) monoliths can be prepared but only polymethacrylate,
poly(styrene–divinylbenzene), and silica-based monoliths are
commercially available. The organic monoliths are generally
applied for the separations of biomolecules, including oligo-
nucleotides, peptides, and intact proteins including protein
isoforms [6, 7]. On the other hand, silica-based monoliths are
well adapted for the separation of small molecules, particularly
since the introduction of the second generation of monoliths in
2011. The latter possesses macropores of 1.2 μm and meso-
pores of 15 nm. As recently reported [8], because of a more
dense packing, this second generation of silica monoliths
provides kinetic performance close to that of columns packed
with porous sub-2 μm particles but with a reduced backpres-
sure. In the case of large molecules, wide-pore silica-based
monoliths are, however, not yet commercially available.
An alternative to monoliths is the use of columns packed
with fully porous sub-2 μm particles. It is well established
since the theoretical works of Giddings, Knox, and Poppe in
the 1970s that small particles result in simultaneous im-
provement of efficiency, optimum velocity, and mass trans-
fer [9–11]. However, the proof of concept of ultra-high-
pressure liquid chromatography (UHPLC) was only demon-
strated in 1997 by Jorgenson et al. [12, 13], and commercial
systems and columns adapted to these high pressures be-
came available in 2004 [14, 15]. Currently, several UHPLC
instruments compatible with pressures up to 1,000–
1,300 bar and numerous column chemistries and dimensions
have become available (>10 providers and >80 chemistries)
[16, 17]. It is also important to notice that columns packed
with wide-pore porous sub-2 μm particles are now available
from various providers, and a few UHPLC applications for
large biomolecules have ever been reported [18–20].
Another possible strategy to improve throughput and/or
resolution in liquid chromatography (LC) is the use of core-
shell technology [21–23]. Basically, this approach consists of
using superficially porous particles composed of a solid inner
core surrounded by a porous outer shell. This technology has
been originally developed by Kirkland in the 1990s and
commercialized under the trademark Agilent Poroshell, to
reduce the diffusion path that macromolecules travel [24].
Today, this strategy is mostly employed with 2.6–2.7 μm
particles for analyzing small molecules, as it permits achiev-
ing equivalent performance to sub-2 μm particles but with a
two- to threefold lower pressure [25–27]. A few applications
demonstrated the interest of such technology for analyzing
peptides and intact proteins [28]. More recently, some wide-
pore core-shell particles became commercially available allow-
ing the analysis of large proteins or even intact mAbs [29].
The goal of the present study was to investigate the
possibilities and limitations of four different innovative
wide-pore column technologies in RPLC, for the analysis
of intact mAbs and their fragments. Two types of monoliths
were tested, namely a prototype inorganic silica-based
monolith and a poly(styrene/divinyl benzene) (PS-DVB)
organic monolith. The performance was compared with that
of a column packed with 3.6 μm core-shell particles pos-
sessing a wide pore size distribution (average pore size of
∼200 Å) and that of a fully porous 1.7 μm particles, with
pore size of ∼300 Å. This work focuses on adsorption/re-
covery of mAbs, kinetic performance with large biomole-
cules, and loading capacity of the different materials.
Experimental
Chemicals, columns
Acetonitrile (gradient grade) was purchased from Sigma-
Aldrich (Buchs, Switzerland). Water was obtained with a
Milli-Q Purification System from Millipore (Bedford, MA,
USA).
IgGmonoclonal antibodies including rituximab (MabThera)
and bevacizumab (Avastin) were purchased from Roche
(Roche Pharma, Switzerland), and panitumumab (Vectibix)
was purchased from Amgen (Switzerland). For fragmentation
of the monoclonal antibodies, dithiothreitol (DTT) and papain
(from Carica papaya) were obtained from Sigma-Aldrich
(Buchs, Switzerland). Trifluoroacetic acid (TFA) and
hydrochloric acid were purchased from Sigma–Aldrich
(Buchs, Switzerland).
Acquity BEH-300 C18 column (150×2.1 mm, 300 Å)
with a particle size of 1.7 μm (ethylene-bridged hybrid,
BEH) was purchased from Waters (Milford, MA, USA).
BEH technology particles are prepared from two monomers:
tetraethoxysilane and bis(triethoxysilyl)ethane which incor-
porates the pre-formed ethylene bridges. The high degree of
cross-linking ensures strong mechanical and hydrolytic sta-
bility. Moreover, the amount of residual silanols is signifi-
cantly lower than it is on pure silica-based materials and
therefore the silanol activity of this BEH phases is low
compared with silica-based phases.
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Aeris Widepore (WP) C18 column (150×2.1 mm)
packed with 3.6 μm core-shell particles (silica) was
purchased from Phenomenex Inc. (Torrance, CA,
USA). ProSwift RP-1S organic polymer (polystyrene–
divinylbenzene) based column (50×4.6 mm) was pur-
chased from Thermo Scientific (Sunnyvale, CA, USA).
New wide-pore silica-based monolithic research samples
(C18, 100×4.6 mm, KN2229, VNr. 4463.06 and
4463.08) were generous gift from Merck KGaA (Darm-
stadt, Germany). Selected physico-chemical properties of
these stationary phases are listed in Table 1. The col-
umns are referred to in the paper as sub-2 μm fully
porous, core-shell, organic monolith, and silica-based
monolith columns.
Equipment, software
All measurements were performed using a Waters Acq-
uity UPLC™ system equipped with a binary solvent
delivery pump, an autosampler, and fluorescence detec-
tor (FL). The Waters Acquity system includes a 5-μL
sample loop and a 2-μL FL flow-cell. The loop is
directly connected to the injection switching valve (no
needle seat capillary). The upper limit of flow rate with
this system is 2 mL/min. The overall extra-column
volume (Vext) is about 15 μL as measured from the
injection seat of the auto-sampler to the detector cell.
The measured dwell volume is around 100 μL. The
extra-column peak variance of this system in gradient
elution mode was found to be negligible. Data acquisition and
instrument control were performed by Empower Pro 2
Software (Waters).
Calculation and data transferring were achieved using
Excel and OriginPro 8 templates.
Apparatus and methodology
Mobile phase composition and sample preparation
For the gradient separation of mAbs and their fragments, the
mobile phase “A” consisted of 0.1 % TFA in water while the
mobile phase “B” was 0.1 % TFA in acetonitrile.
Intact mAbs were injected without dilution, directly from
the concentrated commercial solutions (10 mg/mL rituximab,
25 mg/mL bevacizumab, and 20 mg/mL panitumumab).
IgG monoclonal antibodies possess intramolecular disul-
fide bonds which were reduced with DTT. For this purpose,
0.05 mg of DTT was added to 100 μL mAb concentrated
solution followed by an incubation at 30 °C for 60 min.
Proteins were completely converted to the light-chain (LC)
and heavy-chain (HC) components of the antibodies, ∼25-
and ∼50-kDa fragments, respectively.
To prepare 25-kDa fragments, the reduced antibody (HC
and LC) was digested by the addition of papain (diluted to
100 μg/mL with water) to give a final protein/enzyme ratio
of ∼100:1 (m/m%), the final digestion volume was 200 μL
and was directly injected using low-volume insert vials. The
digestion was carried out at 40 °C for 5 h. This digestion
process yields three main fragments of ∼25 kDa, namely the
native LC, the single-chain Fc (sFc), and the Fab portion of
the HC (Fd). This sample (containing the three 25-kDa
fragments) was used for peak capacity evaluation. This
approach (generating of ∼25 kDa domains) is generally
known as the combinatory strategy (combination of intact
mAb reduction and papain digestion) and could be used for
the characterization and comparison of mAbs by RPLC.
Deamidated mAb samples were created by adding 5 μL
0.1 M HCl into 95 μL rituximab concentrated solution. The
samples were stored under ambient conditions for 24 h; then
Table 1 Physical–chemical properties of the compared columns
Wide-pore silica-based
monolithic research
samples
Proswift RP-1S
(PS-DVB monolith)
BEH300 1.7 μm C18
(packed, fully porous)
Aeris WP 3.6 μm C18
(packed, core-shell type)
Column dimension 100×4.6 mm 50×4.6 mm 150×2.1 mm 150×2.1 mm
Surface chemistry C18 Phenyl C18 C18
Particle size/macro-pore size (μm) measured 1.2 1.0 1.9a 3.6 a
Average pore size/mesopore size (Å) ~257 n.a. ~290 ~200
Total pore volume (cm3/g) 2.93b n.a. 0.69 b 0.08
Total porosity 0.85 0.54 0.67 0.51
Max temperature (°C) 60 70 80 90
pH range 1.5–7.6 1–14 1–12 1.5–9
Max pressure (bar) 200 200 1000 600
aMeasured by the authors [53]
bMeasured and provided by the vendors
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the antibody was reduced to LC and HC fragments by add-
ing 0.05 mg DTT followed by incubation at 30 °C for
60 min.
Heat-stressed degraded samples were produced by incu-
bating the reduced and digested sample at 95 °C for 60 min.
The final sample contains several degradation products of
the 25-kDa fragments.
Recovery study, the effect of temperature
On column adsorption of intact mAbs and their HC and LC
fragments was evaluated in a systematic way. The adsorp-
tion on core-shell and sub-2 μm porous materials was pre-
sented in a previous study [30]. In this current paper, we
compared the adsorption properties of the organic and silica
based monolithic columns. A difficulty could occur when
comparing the recovery of these monolithic and packed
columns, due to the differences in their internal column
diameter, column volume, and porosity. The monolithic
columns have 4.6 mm ID while the others are packed in
2.1 mm ID columns. Keeping the same linear velocity on
these columns means a difference in flow rate, in agreement
with the basic rules of geometrical method transfer [31]. On
the other hand, the injected volume also has to be adjusted in
agreement with column dimensions.
When comparing the recovery on the different columns,
the most evident measure is the observed signal intensity
(e.g., peak area) of the given compound. But in the case of
UVor FL detection, the observed peak area is a function of
mobile phase flow rate and also depends on the injected
quantity. Therefore, the direct comparison of recoveries
between columns having different dimensions is hardly
feasible. Hence, we compared the recovery only on the
two monolithic columns; 1 and 0.5 μL were injected on
the 10- and 5-cm-long columns, respectively (considering
their column volume). Since their diameters are identical,
the same flow rate (1.4 mL/min) was applied for practical
purposes (please note, that in this case the linear velocity
was not identical on the two columns since their porosity is
highly different).
Keeping the quality of a gradient separation on columns
having different lengths, diameters, and porosity (phase ratio),
the rules of linear solvent strength (LSS) theory and general
geometrical method transfer have to be applied [31, 32].
Short gradient runs (5 min on the 5-cm-long organic- and
10 min on the 10-cm-long silica based monoliths) were
carried out at different temperatures ranging from 40 °C
up to the upper temperature limit of the columns (in 10 °C
steps). According to the providers, the silica-based proto-
type material is stable up to 60 °C, while the organic
monolith is stable up to 70 °C. Samples (1 and 0.5 μL) were
injected, and FL detection (excitation at 280 nm, emission at
360 nm, 20 Hz) was performed. Generic linear gradient
from 30 % to 40 % B was applied. The obtained peak areas
(normalized to the maximum observed area as 100 %) were
plotted as a function of temperature.
Column efficiency, peak capacity, and separation impedance
The column efficiency in gradient elution mode is gen-
erally described by the peak capacity. Peak capacity was
first described by Giddings [33] and soon put to good
use by Horvath for gradient separations [34]. For the
comparison of column efficiency in gradient elution
mode, several theoretical and experimental expressions
can be found in the literature [35–40].
Peak capacity depends on various experimental parame-
ters. Among them, the gradient steepness, flow rate, and
temperature play crucial role. For large biomolecules (such
as antibodies and their fragments), temperature should be set
as high as possible for both recovery and efficiency issues
but is limited by either the instrument or the column thermal
stability. Therefore, the optimization of gradient protein
separation generally means the investigation of the effect
of flow rate and gradient steepness on the efficiency (peak
capacity). It seems that, for large biomolecules, the effect of
gradient steepness on the separation power is more domi-
nant than the effect of flow rate. If the very low diffusivity of
large molecules (diffusion in the bulk mobile phase DM and
diffusion in the pores DS or effective diffusion Deff) is
considered, it is easy to demonstrate that the lower the flow
rate (or linear velocity), the higher the obtainable peak
capacity is, in analogy with isocratic plate height (H) equa-
tions [19, 34]. Large molecules do not show an optimum
(minimum) in isocratic H-u representations [19, 41, 42].
In order to have comparable results with these columns of
different dimensions at different flow rates, the rules of LSS
theory and geometrical method transfer were applied [31, 32].
The next formula was used to calculate the gradient
steepness (s) for the given conditions:
s ¼ ϕe  ϕ0ð Þ 
L
tg  t0
 
 u ¼ b  L  u ð1Þ
whereΦ0 is the initial mobile phase composition andΦe is the
final mobile phase composition, L is the column length, tg is
gradient time, t0 is column dead time, u is linear velocity and β
is the so-called time steepness of the linear gradient.
For the peak capacity measurements, the solvent strength
was varied linearly with gradient times. The peak capacity
of each column was investigated at two different linear
velocities (u1∼5.8 cm/min and u2∼11.6 cm/min; these val-
ues correspond to flow rates that are generally used in
practical separations, approximately F1∼0.2 mL/min and
F2∼0.4 mL/min for the narrow bore 2.1 mm ID columns
and F1∼1 mL/min and F2∼2 mL/min for the standard bore
4.6 mm ID columns). The gradient steepness at u1 was set
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between s∼10 and s∼112 %B*cm2/min2 in 7 different ex-
perimental points, while at u2, it was set in the range of s∼
39–460 %B*cm2/min2 again at seven different values. Be-
side the flow rate and gradient steepness, the effect of
temperature on column efficiency was also evaluated since
it is a key parameter in protein separation. In the first
comparison, all columns were thermostated at 60 °C (this
is the limitation of the new wide-pore silica-based mono-
lithic research sample) and compared at the same tempera-
ture. Since the diffusivity (and therefore the separation
efficiency) of large analytes strongly depend on the temper-
ature, it is of great interest to compare the performance of
these columns at their maximum temperature. In this com-
parison, the temperature was set at 60 °C for the silica-based
monolithic column, 70 °C for the organic monolith, 80 °C
for the sub-2 μm porous, and 90 °C for the core-shell
columns. The injected volume was set in agreement with
the rule of geometrical transfer. It was equal to 1 μL for the
silica-based monolithic column, 0.5 μL for the organic
monolith, and 0.3 μL for the two packed columns.
The above explained conditions can be used to directly
compare the efficiency of these columns of different dimen-
sions in gradient elution mode, for protein separation. How-
ever, the experimentally observed peak capacity (nC) values
are not comparable since peak capacity also depends on
column length. Therefore, the peak capacities extrapolated
to 1 m column length (nC.M) were considered in this com-
parison. When maintaining constant the gradient steepness,
the following formula can be written:
nc;M ¼ nc
ﬃﬃﬃﬃﬃﬃﬃﬃ
100
L
r
ð2Þ
Where nc,M is the peak capacity extrapolated to 1 m
length and L is the column length in centimeters.
Peak capacities were experimentally determined from the
gradient time and the average peak widths measured at 50 %
height (w50 %). The following equation was used to estimate
the peak capacity based on peak widths at 4σ, corresponding
to a resolution of Rs=1 between consecutive peaks:
nc ¼ 1þ tg1:699  w50% ð3Þ
The sample containing the three main fragments of
∼25 kDa, (LC, sFc, and Fd) of rituximab was injected in
this comparative study. Therefore, the peak width of the
three main peaks was used for calculating an average peak
capacity. To avoid the imprecision associated with the mea-
surement of peak widths at baseline for antibody fragments
often containing closely related variants, the peak width at
half height was preferred in this study. Thus, impurities
present in the sample and partially resolved from the
main component did not confuse the measurement of
peak capacity values.
During the experiments, Φe–Φ0 was kept constant (10 %)
for all columns. But for maintaining similar apparent reten-
tion on the different stationary phases, Φ0 was set at 28 %B
on the silica-based monolithic column, 27 %B on the or-
ganic monolith column, and 29 % on the two packed
columns.
When comparing the efficiency of these columns, the
peak capacity per meter was plotted against the gradient
span (expressed in time per column length dimension such
as minute per meter). The gradient span (Sg) in this case was
calculated as:
Sg ¼ tg 100L
 
ð4Þ
The column performance also depends on column per-
meability (Kv) and retention time, the latter being related to
column dead time and/or gradient time. Therefore, peak
capacity plots do not give information about the overall
quality of the separation (e.g., achievable separation time)
but only about the reachable peak widths.
When the flow rate is changed but the gradient steepness
is kept constant, the so-called gradient kinetic plots can be
easily constructed. Different gradient kinetic plots have been
presented by Wang et al., Zhang et al., Haddad et al., Ruta et
al., and Desmet et al. [43–48]. In our case, it was more
interesting to investigate the opposite case when experimen-
tal conditions corresponded to different gradient steepness at
constant flow rate. By analogy to Knox’s separation imped-
ance concept [49], similar representation of kinetic perfor-
mance can be constructed by calculating the peak capacity
per unit time and per unit pressure values, according to the
next formula [19, 50, 51]:
PPT ¼ nc
tg ΔP ð5Þ
where PPT is the peak capacity per unit time and per unit
pressure value and ΔP is the column pressure drop (the
maximum pressure measured during the gradient program,
corrected for extra-column pressure drop). Plots of PPT as a
function of gradient spans were constructed and compared
for two sets of linear velocity and two sets of temperatures
(similarly to peak capacity plots, the PPT values were ex-
trapolated for 1 m column length (PPTM) in order to nor-
malize these values and make them independent on column
length).
Evaluating the loading capacity of the columns
The loading capacity of the different materials (monolith,
fully porous, and core-shell) was compared under real-life
conditions. Reduced rituximab sample was used to evaluate
the loadability of these columns. Different amounts of the
antibody (2, 5, 10, 20, 40, 60, 80, 100, and 200 μg) were
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injected. The experiments were conducted at one given
linear velocity (u1∼5.8 cm/min) with a given gradient span
(Sg=100 min/meter). For the experiments, Φe–Φ0 was kept
constant (10 %). Similar apparent retention was maintained
on the different stationary phases. All columns were ther-
mostated at 60 °C. The chromatograms were recorded at
360 nm (20 Hz, excitation at 280 nm). Finally, the load-
ability was evaluated by measuring and plotting the peak
widths and the percent change in peak capacity as a function
of the loaded protein amount (nanograms). For a fair com-
parison, on the x-axis, the loaded amount per column vol-
ume (expressed in nanograms per cubic millimeter) was
indicated.
Results and discussion
Recovery, adsorption of antibody fragments
In a previous study dealing with the analysis of mAbs in
RPLC [30], we have demonstrated that the adsorption phe-
nomenon with intact mAbs and their fragments could be
problematic since it was significantly higher, compared with
proteins of equivalent size. According to this study, the
recovery was directly related to the size of intact or digeste-
d/reduced mAbs, the largest fragments being much more
affected by adsorption. Another conclusion from this work
was that the low recovery of mAbs in RPLC was predom-
inantly attributed to strong secondary interactions (ionic and
hydrogen bonds) with the stationary phase, while the effect
of alkyl chain hydrophobicity (C18 versus C4) was less
relevant. The best solution to decrease the importance of
adsorption was to increase the mobile phase temperature in
order to reduce the strength of secondary interactions [53].
Because the two monolithic columns have 4.6 mm while
the packed columns have 2.1 mm ID, it is impossible to
directly compare these four columns. For this reason, and
also to avoid repeating some data previously published, we
have only measured the adsorption on both the silica-based
monolith and the organic monolith. The recoveries obtained
with the column packed with 3.6 μm core-shell particles
possessing a wide pore size distribution and that of fully
porous 1.7 μm particles, with pore size of ∼300 Å can be
found elsewhere [30], and were obtained using the same
experimental setup and similar model antibodies and their
fragments.
Figure 1 shows the data obtained for two intact mAbs and
their fragments, namely rituximab and bevacizumab. The
recoveries were expressed as normalized peak areas and
were investigated as a function of mobile phase temperature.
The temperature ranges were 40–60 °C for the silica-based
monolith and 40–70 °C for the organic monolith. In agree-
ment with the previous study [30], recoveries were much
more critical for intact mAb of 150 kDa followed by HC of
50 kDa and the LC of 25 kDa. For example, the recovery on
intact rituximab at 60 °C was equal to less than 10 % on the
silica-based monolith while the recovery values increased to
52 % and >99 % for HC and LC, respectively. Similar
behavior was observed on the organic monolithic column
but with better recovery in terms of absolute values. In
addition, the curves were very similar for both rituximab
and bevacizumab, but the adsorption seemed to be slightly
more pronounced for bevacizumab.
On the other hand, the recoveries were significantly
improved with elevated temperature, and adsorption was
Fig. 1 Recovery of a rituximab and its heavy (HC) and light chains
(LC) and b bevacizumab and its heavy (HC) and light chains (LC)
(normalized peak areas against column temperature). Columns: organic
monolith (ProSwift RP-1S) and wide-pore silica-based monolith
(Merck), temperature: from 40 °C up to 70 °C, injected volume:
0.5 μL, detection: fluorescence (excitation at 280 nm, emission at
360 nm). Mobile phase A—0.1 % TFA in water, mobile phase B—
0.1 % TFA in acetonitrile. Gradient: from 30 % to 40 % B in 5 min (for
ProSwift RP-1S 5 cm column) and in 10 min (for 10 cm long Merck
wide-pore monolith research sample), flow rate, 1.4 mL/min
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generally acceptable in the temperature range between 60
and 70 °C, except for the intact mAbs on the silica-based
monolith. As example, on the latter, the recovery of intact
rituximab was increased from 0 % to 9 % when raising
temperature from 40 to 60 °C, while the recovery of HC
and LC was increased from 6 % to 51 % and from 92 % to
99 % between 40 and 60 °C, for the same stationary phase.
A good solution to further limit recovery issues would be to
have silica-based monolithic columns stable at higher
temperatures.
Finally, as reported in Fig. 1, some significant differences
in terms of adsorption/recovery were observed between the
silica-based and the organic monolith. Indeed, at a temper-
ature of 60 °C, the recoveries on intact rituximab were equal
to 9 % and 87 % for the silica-based and the organic
monolith, respectively. The same behavior was also ob-
served on mAb fragments. This observation was probably
related to the ion exchange capability of both columns and
also probably to the hydrophobicity of the material (phenyl
versus C18). Indeed, even if the silica-based monolith
employed in the present study was endcapped, there should
still be a significant number of residual silanols and thus,
can participate in hydrogen-bonding interactions. According
to the observations made on recovery, the amount of nega-
tively charged groups is probably significantly higher at the
surface of the silica-based compared with the organic mono-
lith. Another explanation for the difference of recovery
could be the difference in column chemistry and hydropho-
bicity. In fact, the silica-based monolith is bonded with C18
chain while the organic-based one possesses phenyl bond-
ing, and additionally, there are no stagnant zones
(mesopores) in the organic polymer monolith. There is an
evident difference of hydrophobicity between such bonding
that could also contribute to the better recoveries observed
on the organic monolith.
Column efficiency in gradient mode for antibody fragments
In this section, a systematic study presents the peak capacity
and gradient separation impedance (PPT) of silica-based
wide-pore monolith, organic monolith, a wide-pore sub-
2 μm fully porous material, and a 3.6 μm core-shell mate-
rial. Table 1 summarizes physical–chemical properties of
these columns.
This comparison allows us to directly compare the perfor-
mance of these stationary phase materials possessing different
structures and morphologies, in gradient elution mode. In
practice, proteins are generally separated in gradient elution
mode at elevated temperature. Elevated temperature is benefi-
cial because it decreases the strength of secondary interactions
between residual silanols and positively charged biomolecules.
Moreover, the use of high temperature strongly enhances ana-
lyte diffusion. Furthermore, ion-pairing reagent, namely TFA,
was added to the mobile phase to improve peak shape in the
case of proteins separation. For the reason of emulating real-
life conditions, a minimal column temperature of 60 °C was
considered; 0.1 % TFA was added to the mobile phase, and
gradient spans varied between Sg=50 and 600 min/m at u1∼
5.78 cm/min and Sg=25 and 300 min/m at u2∼11.56 cm/min,
which are fairly common in the current practice. (For better
understanding, this Sg range corresponds to gradient times
ranging between 7.5 and 90 min for a 150×2.1 mm column
at 0.2 mL/min flow rate.) Beside the gradient steepness and
flow rate, the effect of temperature was also evaluated. In a first
instance, all the columns were thermostated at 60 °C (maxi-
mum recommended temperature for the silica-based mono-
lith), and their efficiencies were compared. Then, the
performance of the columns was measured at their maximum
operational temperature. The test solution was a reduced and
papain-digested rituximab that contains three main fragments
of around ∼25 kDa (LC, sFc, and Fd domains).
The influence of the gradient steepness and linear veloc-
ity on column performance was investigated under several
gradient elution conditions. These experimental variables
are directly related to the mobile phase flow-rate and the
gradient time duration which are often used to adjust a
proper separation in practical work. The former has a direct
influence on the peak width while gradient duration plays an
important role on the resolution as it affects the retention
factor of the solute in the mobile phase composition upon
elution. It should be stressed that these conditions are not
meant to maximize the peak capacity for any particular
column or compound, as sometimes higher peak capacity
can be achieved by choosing longer gradient times or lower
flow rates. Instead, we merely wanted to identify a set of
conditions allowing a fair comparison within a practically
acceptable time frame.
Figure 2a shows the obtained peak capacity per meter
values as a function of gradient span at a relatively low
linear velocity (u1∼5.8 cm/min) for all columns. The organ-
ic monolith gave the lowest peak capacity with a maximum
peak capacity of nc,M∼360 reached with the Sg=600 min/m
gradient span (that corresponds to a ∼30 min long gradient
for the 50×4.6 mm column). The silica-based wide-pore
monolith showed slightly better performance. The sub-
2 μm fully porous material performed very similar peak
capacity (nc,M∼405 at Sg=600 min/m) than the silica-
based monolith. Finally, significantly higher efficiency was
attained with the core-shell material, and the highest peak
capacity (nc,M∼490) was achieved.
When the mobile phase velocity was increased (u2∼
11.6 cm/min), the two packed columns outperformed the
two monolith columns in terms of peak capacity (Fig. 2b).
At this linear velocity, the same efficiency was obtained for
both monolith columns within the whole investigated gra-
dient span range. At the applied maximum gradient span,
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the packed columns outperformed the monolith columns by
a factor of 1.6. There was a remarkable loss in peak capacity
at this higher linear velocity compared with the values
obtained at low velocity (Fig. 2b and a). In the case of the
silica-based monolith column, the loss was about 40 %,
while this decrease was 23 % with the organic monolith
column and around 20 % with the core-shell material while
it was nearly negligible (7–8 %) with the fully porous sub-
2 μm column. The significant efficiency loss of the core-
shell material compared with the packed fully porous sub-
2 μm one can probably be explained with its relatively large
particle size (dp=3.6 μm), since the contribution of the mass
transfer resistance to the total H is a function of particle
diameter.
Another representation of column efficiency is shown in
Fig. 3. In this case, the quality of separation is considered on
the basis of peak capacity, column permeability, and analy-
sis time as well. Figure 3a shows the peak capacity per
pressure and time unit (PPT) values as a function of the
gradient span at u1∼5.8 cm/min, and at 60 °C for all col-
umns. In this representation, the higher the PPT value, the
lower the “separation impedance” is. These plots illustrate
that the fastest separation can be achieved with the core-
shell and the new silica-based monolith columns. These two
columns drastically outperformed the sub-2 μm fully porous
and the organic monolith columns. Surprisingly, the organic
monolith showed two times lower permeability than the
silica-based monolith, in spite of the slight difference in
their average macropore size (∼1 μm for the organic and
1.2 μm for the silica-based monolith). The sub-2 μm porous
material showed a relatively poor efficiency due to its very
low permeability compared with the other materials.
When increasing the mobile phase velocity (Fig. 3b), the
3.6 μm core-shell material provided the best efficiency and
therefore offered the chance of the fastest separation. The
silica-based monolith also provided good performance,
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Fig. 2 Peak capacity plots of rituximab fragment sample at u1∼
5.8 cm/min (a) and at u2∼11.6 cm/min (b) linear velocity. Columns:
wide-pore silica-based monolith (Merck), ProSwift RP-1S, BEH300
C18, and Aeris WP; temperature, 60 °C for all columns. Other exper-
imental conditions are specified in section on “Column efficiency, peak
capacity, separation impedance”
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Fig. 3 Gradient separation impedance (peak capacity per time unit and
per pressure unit versus gradient steepness) plots of rituximab fragment
sample at u1∼5.8 cm/min (a) and at u2∼11.6 cm/min (b) linear veloc-
ity. Columns: wide-pore silica-based monolith (Merck), ProSwift RP-
1S, BEH300 C18, and Aeris WP; temperature, 60 °C for all columns.
Other experimental conditions are specified in section “Column
efficiency, peak capacity, separation impedance”
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while the fully porous sub-2 μm and the organic monolith
gave the lowest PPT values (the highest separation imped-
ance). When comparing these two latter columns, they pres-
ent the same separation impedance when high peak capacity
is required for a given separation (corresponds to the range
when Sg≥200 min/meter) while the organic monolith sig-
nificantly outperforms the sub-2 μm porous material when
fast gradients are applied (e.g., Sg<100 min/m).
When working at the maximal temperature of the differ-
ent stationary phases, the efficiency of protein separations
can be considerably improved. Figure 4 presents the peak
capacity per meter values obtained at their maximum oper-
ational temperature. Applying low flow rate (Fig. 4a), the
maximum peak capacity of nc,M∼725 was reached with the
sub-2 μm porous column (T=80 °C) at Sg=600 min/m
gradient span. The core-shell column (T=90 °C) reached
its limitation in terms of peak capacity at Sg∼500 min/m
gradient span. The maximum peak capacity that can be
achieved with this core-shell material is nc,M∼700. Howev-
er, it has to be mentioned that, in Sg=50–500 range, the
core-shell material outperformed the sub-2 μm fully porous
packing. The silica-based monolith (T=60 °C) and the or-
ganic monolith (T=70 °C) provided the same peak capacity.
With the monoliths, nc,M∼400 was reached when applying
the longest gradient run.
It is important to mention that temperature has indeed a
strong impact on efficiency of gradient RPLC protein sepa-
rations. The maximum achievable peak capacity with the
core-shell material was improved by a factor of 1.4 at T=
90 °C compared with T=60 °C. With the sub-2 μm fully
porous material, the gain in column efficiency was more
pronounced. The maximum peak capacity was increased by
a factor of 1.8 between T=80 and 60 °C. In the case of
organic monolith column, 1.12 times higher peak capacity
was attained when working at T=70 °C compared with T=
60 °C.
Figure 4b shows the peak capacity of the four columns at
their maximum temperatures and at elevated mobile phase
velocity. Again, at higher mobile phase velocity, the effi-
ciency became markedly lower compared with low mobile
phase velocity. The packed columns showed very similar
behavior that was shown and explained at Fig. 4a. However,
the difference between the two monolith columns was more
pronounced. At a mobile phase velocity of u2∼11.6 cm/min,
the organic monolith gave 90 % of the peak capacity that
was achieved at u1∼5.8 cm/min, while the silica-based
monolith performed only 65 % of that attained at half the
mobile phase velocity. Therefore, when applying high mo-
bile phase velocity, the organic monolith outperformed the
silica-based monolith in terms of achievable peak capacity.
Working at the maximum temperature and comparing the
column performance in PPT plots (Fig. 5), the benefit of
core-shell material became obvious. This 3.6 μm superfi-
cially porous material provided high peak capacity, and
beside this fact, its permeability is also favorable because
of its relatively large particles. The other important feature
of this material is its high temperature stability that enables
to perform very efficient and fast antibody separations. At
low mobile phase velocity (Fig. 5a), the new silica-based
monolith showed some benefits against the organic mono-
lith and sub-2 μm porous materials, but this gain was less
important when working at a higher flow rate (Fig. 5b). In
this case, the silica-based monolith, the organic monolith,
and the sub-2 μm fully porous packed column presented
very similar impedance and produced lower performance
than the core-shell type 3.6 μm packing.
Evaluation of the loading capacity
Sample loading capacity is proportional to the stationary
phase volume or phase ratio, and it is expected that the
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Fig. 4 Peak capacity plots of rituximab fragment sample at u1∼
5.8 cm/min (a) and at u2∼11.6 cm/min (b) linear velocity. Columns
and temperature: wide-pore silica-based monolith (Merck) (60 °C),
ProSwift RP-1S (70 °C), BEH300 C18 (80 °C), and Aeris WP (90 °
C). Other experimental conditions are specified in section “Column
efficiency, peak capacity, separation impedance”
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phase ratio of monolithic and packed columns could be very
different. Moreover, the porosity of silica-based (ε=0.85)
and organic polymer-based monoliths (ε=0.54) were also
very different. In the case of fully porous and core-shell type
packed columns, the volume of the porous parts of the
stationary phase is also completely different. The volume
fraction of the porous material of the shell in the column is
1–(Ri/Re)
3, where Re and Ri are the radii of the solid core
and the particle, respectively. The volume fraction of the
porous shell in the case of Aeris WP particles was estimated
at about 34 %.
Overloading of the stationary phase is always more sig-
nificant with ionized compounds in RPLC separations [52].
Proteins can be retained on both ionic and hydrophobic sites
of the stationary phase, therefore the lower expected load-
ability of the core-shell type material and silica-based mono-
lith can probably be compensated by their apparently higher
ion exchange capability, compared with the fully porous
hybrid sub-2 μm (BEH) and organic polymer-based
(ProSwift) materials [53]. An additional consideration is that
differences in pore size distribution of the sorbents can also
play a significant role in overloading, since exclusion of
proteins from pores can induce serious overloading effects.
Hence, because of the huge differences in stationary
phase structure/morphology of the compared materials, the
evaluation of the sample loading capacity is of interest but
could be difficult to explain. The loading capacities of the
different materials were compared in a systematic way. The
experimental conditions were described in the section
“Evaluating the loading capacity of the columns.”
Figure 6a shows the absolute change in peak width of the
light-chain fragment of rituximab against loaded amount. In
this comparison (under the given conditions), the silica-
based monolith provided somewhat broader peaks (w1/2∼
0.13 min) than the other three columns (w1/2∼0.10 min). In
the case where the loaded amount of this light-chain frag-
ment was more than 10 ng/mm3, the peak width on the
organic monolith column started to broaden more rapidly
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Fig. 5 Gradient separation impedance (peak capacity per time unit and
per pressure unit versus gradient steepness) plots of rituximab fragment
sample at u1∼5.8 cm/min (a) and at u2∼11.6 cm/min (b) linear veloc-
ity. Columns and temperature: wide-pore silica-based monolith
(Merck) (60 °C), ProSwift RP-1S (70 °C), BEH300 C18 (80 °C), and
Aeris WP (90 °C). Other experimental conditions are specified in
section “Column efficiency, peak capacity, separation impedance”
Fig. 6 Absolute of the peak width of light-chain fragment (a) and
relative change in peak capacity (b) in function of the loaded mass/
column volume. Columns: wide-pore silica-based monolith (Merck),
ProSwift RP-1S, BEH300 C18, and Aeris WP; temperature, 60 °C for
all columns. Other experimental conditions are specified in
section “Evaluating the loading capacity of the columns”
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compared with the other columns. When the loaded amount
was larger than 30 ng/mm3, the silica-based monolith gave
sharper peak than the organic monolith. Surprisingly, the
change in absolute peak width was less pronounced on the
silica-based monolith than on the packed columns. When
the loaded amount was comprised between 100 and
200 ng/mm3, the silica monolith performed same peak width
as the packed columns.
Figure 6b shows another representation of loading capac-
ity, namely the relative change in peak capacity as a function
of loaded amount. This figure obviously confirms that over-
loading is more critical in the case of organic monolith while
the silica monolith is less problematic in terms of overload-
ing. Unexpectedly, the fully porous and core-shell type
materials showed the same behavior, in spite of the huge
difference in their porous volume. Probably, the loadability
on the core-shell material can be compensated by its rela-
tively high ion-exchange activity and/or different pore size
distribution. Since there is no criterion on setting the limits
of column overloading, an arbitrary value of 20 % relative
decrease in peak capacity was considered as acceptable. The
core-shell, the sub-2 μm fully porous, and the organic
monolith columns reached 20 % decrease in peak capacity
when approximately 20–25 ng/mm3 of the light-chain frag-
ment was loaded and about 65–70 ng/mm3 on the silica-
based monolith.
As a conclusion, for ∼25-kDa antibody fragment, the
loadability of the columns can be ranked as: (1) new wide-
pore silica-based monolithic, (2) the fully porous and super-
ficially porous packed columns (BEH and Aeris WP), and
(3) the organic monolith. This latter one showed approxi-
mately a threefold lower sample loading capacity than the
new silica-based monolith. Probably, other type of proteins
could show different behavior and the loading capacity of
the columns ranked in a different way. In this study, we
focused only on antibody fragments.
Applications, examples
Proteolytic digestion of a mAb (peptide mapping) followed
by gradient RPLC-tandem mass spectrometry analysis
(“bottom-up approach”) is generally the method of choice
for the identification and quantification of chemical modifi-
cations of mAbs [54, 55]. However, this approach is time-
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Fig. 7 Separation of LC (peak 1) and HC (peak 2) fragments and some
variants of deamidated rituximab sample. The supposed deamidated
form of the LC is indicated with arrows. On the 5-cm-long ProSwift
column (b), no change was observed in the chromatographic profile
when injecting the deamidated and non-deamidated samples. Columns
and applied temperature: wide-pore silica-based monolith (a) at 60 °C,
ProSwift RP-1S (b) at 70 °C, BEH300 C18 (c) at 80 °C, and Aeris WP
(d) at 90 °C; linear velocity, u∼5.78 cm/min; detection: fluorescence
(excitation at 280 nm, emission at 360 nm). Other experimental con-
ditions are specified in section “Applications, examples”
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consuming and can induce putative modifications during the
complex and lengthy sample preparation [55]. Alternatively,
the analysis of intact or fragmented mAbs requires very little
sample preparation and can provide a high-throughput al-
ternative to peptide mapping.
Using RPLC under reducing conditions, the LC generally
elutes in a single sharp peak, while HC fragments elute often
in heterogeneous peaks. Another current approach is the so-
called limited proteolysis that means the analysis of IgG1
and IgG2 Fab and Fc domains using RPLC or RPLC–time-
of-flight–mass spectrometry. This approach facilitates the
confirmation of chemical and post-translational modifica-
tions such as N-terminal cyclization, oxidation, deamida-
tion, and C-terminal processed lysine residues [20, 56–59].
A new combinatory strategy was presented by Yan et al.
to analyze the heterogeneity of LC, sFc, and Fd of an IgG
molecule released by papain cleavage under mild reducing
conditions [60].
In this section, the performance of the four columns was
investigated for a real monoclonal antibody separation. In
the first example, rituximab was slightly deamidated and
then reduced (see section on “Mobile phase composition
and sample preparation”). The obtained chromatograms of
the resulting LC and HC fragments are presented in Fig. 7
(experimental conditions are specified in section on
“Applications, examples”). Please note that column lengths
were different. Surely, a 10–15-cm-long organic monolith
column would perform significantly better that the 5 cm one.
The probable deamidated form of the HC (indicated with
arrow in Fig. 7) can be slightly separated with the 1-cm-long
silica-based monolith and with the 15-cm-long sub-2 μm fully
porous columns and can be well resolved by using the 15-cm-
long core-shell type column, using generic conditions.
The second example presents a comparison of the chro-
matographic profile of a heat-stressed, papain-digested, and
reduced rituximab sample (see section on “Mobile phase
composition and sample preparation”). This sample contains
several variants/degradants of the LC, sFc, and Fd domains
(Fig. 8). The two packed columns were able to resolve
many of these fragments while the two monolithic col-
umns can separate only a limited number of these
degradants. In this example, the packed columns
showed better performance than the monolithic columns
(but there are significant differences in column lengths).
Because of the favorable permeability of the new silica-
based monolith column, coupling various columns in
series could be a promising approach and probably
could yield far better separation power.
Fig. 8 Separation of several fragments and variants of heat-stressed-
reduced and papain-digested rituximab sample. Columns and applied
temperature: wide-pore silica-based monolith (a) at 60 °C, ProSwift
RP-1S (b) at 70 °C, BEH300 C18 (c) at 80 °C, and Aeris WP (d) at
90 °C; linear velocity; u∼5.8 cm/min, detection: fluorescence (excita-
tion at 280 nm, emission at 360 nm). Other experimental conditions are
specified in section “Applications, examples”
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Conclusion
Recent RPLC phases possessing significant differences
in structure/morphology were evaluated for the analysis
of intact mAbs (∼150 kDa) and their fragments (∼25–
50 kDa). Two monolithic materials were considered,
namely a prototype wide-pore silica-based column and
a PS-DVB organic monolithic stationary phase. Two
packed columns were also employed, namely a column
packed with wide-pore fully porous particles of 1.7 μm
and with wide-pore core-shell particles of 3.6 μm. Var-
ious model IgG1 and IgG2 mAbs were considered (rit-
uximab, panitumumab, and bevacizumab), and the
stationary phases were compared in terms of adsorp-
tion/recovery, kinetic performance in the gradient elution
mode, and loading capacity.
In terms of adsorption/recovery, the packed columns were
investigated in a previous study [30], and it was concluded
that the adsorption was more critical on the silica-based core-
shell material than on the hybrid sub-2 μm porous material
probably because of a higher ion exchange capability on the
former one. Regarding monoliths, the recoveries on organic
monolith were excellent, above all when working at elevated
temperature. On the other hand, some significant adsorption
problems were observed with the prototype silica monolith,
particularly with intact mAbs and large fragments (50 kDa).
Kinetic performance was compared using peak capacity
measurements on various mAb fragments of ∼25 kDa. Because
the tested columns possessed different column lengths and
internal diameters, some adaptations were made to the tradi-
tional gradient kinetic plot methodology. The performance was
evaluated at low and high mobile phase linear velocity and
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Fig. 9 Schematic comparison of the different column performance based on different parameters: recovery, loading capacity, efficiency,
permeability, selectivity, and column temperature stability
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using two mobile-phase temperatures, namely 60 °C for all
columns or the maximal working temperature of all columns.
Whatever the flow rate and mobile phase temperature were, the
core-shell-type material outperformed the three other stationary
phases. It provided high peak capacity and high permeability
and was compatible with temperature up to 90 °C. On the other
hand, the organic monolith suffered from a low permeability
compared with the prototype silica-based monolith. Lastly, the
sub-2 μm porous phase provided peak capacity close to that of
3.6μmcore-shell but was only able to work up to 80 °C, and its
permeability was significantly lower.
Finally, the loading capacity also varied strongly between
columns. In the case of mAb fragments, the prototype silica-
based monolith was the most interesting one while the
organic monolith overloaded more rapidly (threefold lower
sample loading capacity than the prototype silica monolith).
Despite very different particle morphologies, the loading
capacity of packed columns was comparable.
Numerous parameters should be considered to adequate-
ly select the best column for a given purpose, including the
recovery (adsorption), loading capacity, peak capacity
(efficiency), permeability, selectivity, and thermal stability.
To select the best column for a given application, all of these
figures of merits have been combined in the spidergrams of
Fig. 9 for the four investigated columns. To conclude, the
four RPLC phases present some advantages and limitations,
but all of them could be employed for the analysis of IgG1
and IgG2 mAb fragments (HC, LC, sFc, and Fd domains).
This confirms the interest of RPLC approach for analyzing
such large biomolecules.
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